• Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Oncology
  • Nephrology
  • Neurology
  • Pulmonology

The 23-Valent Pneumoccocal (Pneumovax) Vaccine: For Which Patients?

Poll

For which of these patients would you give the 23-valent pneumoccocal vaccine?

Which of the following should get the 23-valent pneumoccocal (Pneumovax) vaccine per the Advisory Committee on Immunization Practices (ACIP) guidelines?

19-year-old who smokes a pack a day
16-year-old with diabetes mellitus
70-year-old who previously received a dose at age 64
All of the above
Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Interview with Kelly Moore, MD, MPH, president, chief executive officer, Immunization Action Coalition
Related Content
FDA grants Novavax COVID-19 vaccine full approval for high risk groups / image credit ©Waldenmarus/stock.adobe.com

FDA Grants Novavax COVID-19 Vaccine Full Approval for High-Risk Groups

Grace Halsey
May 20th 2025
Article

Nuvaxovid (NVX-CoV2373) is indicated for those aged ≥65 years and aged 12 to 64 years with at least one condition that puts them at high risk for severe infection.

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

Sydney Jennings
May 7th 2025
Podcast

PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.

Bacterial Vaginosis Recurrence Drops with Partner Treatment: Daily Dose / image credit: ©New Africa/AdobeStock

Bacterial Vaginosis Recurrence Drops with Partner Treatment: Daily Dose

Sydney Jennings
April 28th 2025
Article

Your daily dose of the clinical news you may have missed.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Oral Gepotidacin Noninferior to Standard Therapy for Gonorrhea in Phase 3 Trial

Oral Gepotidacin Noninferior to Standard Therapy for Gonorrhea in Phase 3 Trial

Sydney Jennings
April 15th 2025
Article

Data from the EAGLE-1 study found gepotidacin to be noninferior to ceftriaxone plus azithromycin for treating uncomplicated urogenital gonorrhea.

RSV Vaccine Uptake Low Among Eligible Populations, Large-Scale Analysis Finds

RSV Vaccine Uptake Low Among Eligible Populations, Large-Scale Analysis Finds

Sydney Jennings
April 9th 2025
Article

AAAAI 2025: RSV vaccine and immunoprophylaxis uptake remained low in 2024 across infants, pregnant individuals, and older adults.

© 2025 MJH Life Sciences

All rights reserved.